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Capsular polysaccharides enable clinically important clones of Klebsiella pneumoniae to
cause severe systemic infections in susceptible hosts. Phage-encoded capsule
depolymerases have the potential to provide an alternative treatment paradigm in
patients when multiple drug resistance has eroded the efficacy of conventional
antibiotic chemotherapy. An investigation of 164 K. pneumoniae from intensive care
patients in Thailand revealed a large number of distinct K types in low abundance but four
(K2, K51, K1, K10) with a frequency of at least 5%. To identify depolymerases with the
capacity to degrade capsules associated with these common K-types, 62 lytic phage
were isolated from Thai hospital sewage water using K1, K2 and K51 isolates as hosts;
phage plaques, without exception, displayed halos indicative of the presence of capsule-
degrading enzymes. Phage genomes ranged in size from 41–348 kb with between 50 and
535 predicted coding sequences (CDSs). Using a custom phage protein database we
were successful in applying annotation to 30 - 70% (mean = 58%) of these CDSs. The
largest genomes, of so-called jumbo phage, carried multiple tRNAs as well as CRISPR
repeat and spacer sequences. One of the smaller phage genomes was found to contain a
putative Cas type 1E gene, indicating a history of host DNA acquisition in these obligate
lytic phage. Whole-genome sequencing (WGS) indicated that some phage displayed an
extended host range due to the presence of multiple depolymerase genes; in total, 42
candidate depolymerase genes were identified with up to eight in a single genome. Seven
distinct virions were selected for further investigation on the basis of host range, phage
morphology and WGS. Candidate genes for K1, K2 and K51 depolymerases were
expressed and purified as his6-tagged soluble protein and enzymatic activity
demonstrated against K. pneumoniae capsular polysaccharides by gel electrophoresis
and Anton-Paar rolling ball viscometry. Depolymerases completely removed the capsule
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in K-type-specific fashion from K. pneumoniae cells. We conclude that broad-host range
phage carry multiple enzymes, each with the capacity to degrade a single K-type, and any
future use of these enzymes as therapeutic agents will require enzyme cocktails for utility
against a range of K. pneumoniae infections.
Keywords: Klebsiella pneumoniae, bacteriophage, capsule depolymerase, whole-genome sequencing (WGS),
jumbo phage, capsular polysaccharide, alternative antibacterial therapy
INTRODUCTION
Extracellular polysaccharide and polypeptide capsules are major
virulence determinants of Gram-positive and Gram-negative
pathogens, aiding colonisation of mucosal surfaces and protecting
invasive bacteria from immune recognition and killing by cellular
and humoral immune mechanisms during infection of susceptible
hosts. They are key contributors to the enormous diversity of
bacterial surfaces and provide the interface >with their immediate
external environment (Roberts, 1996; Mostowy and Holt, 2018).
The rising incidence of antibiotic resistance in bothnosocomial and
community-acquired pathogenic bacteria poses a serious threat to
global health, compounded by the paucity of new antibiotics in the
drug development pipeline, and has sparked renewed interest in
alternative, non-antibiotic modes of treatment for bacterial
infections, including the therapeutic use of bacteriophage
(Lin D. M. et al., 2017), stimulation of immune cellular functions
(Haney and Hancock, 2013) and the development of agents that
advantageously modify the antibiotic resistance and virulence of
bacterial pathogens (Mellbye and Schuster, 2011; Taylor, 2017).
There is growing evidence that rapid removal of the protective
capsule during infection facilitates elimination of the invading
pathogen from the host. This approach, which circumvents the
consequences of acquisition of genes conferring antibiotic
resistance, was initially investigated in the pre-antibiotic era by
Dubos and Avery using an enzyme preparation from cultures of a
peat soil bacterium to selectively remove the polysaccharide
capsule from the surface of type III pneumococci (Avery and
Dubos, 1930; Avery and Dubos, 1931; Dubos and Avery, 1931;
Goodner et al., 1932; Francis et al., 1934). The enzyme selectively
degraded the capsule; administration to mice prior to challenge
with type III pneumococci gave rise to type III-specific protection;
the enzyme terminated normally fatal type III pneumococcal
dermal infection in rabbits and abrogated spread of the
pneumonic lesion in infected cynomolgus monkeys. More
recently, a depolymerase from an environmental bacterium was
shown to prevent lethal infection in mice infected with a highly
virulent strain of Bacillus anthracis (Negus et al., 2015).
Bacteriophage, predominantly of the Podovirdae, Siphoviridae
and Myoviridae families, are a primary source of depolymerase.
These enzymes usually manifest as structural proteins such as tail
fibres and baseplates but may also be present as soluble proteins
during the lytic cycle; they facilitate initial binding to the host
bacterium and effect degradation of the capsule to initiate phage
infection (Pires et al., 2016; Knecht et al., 2020). These enzymes
show promise as putative therapeutic agents. Endosialidase E
derived from an Escherichia coli K1-specific phage rapidly and
selectively degraded the polysialic acidK1capsule that enables these
bacteria to cause potentially lethal sepsis and meningitis in the
neonate (Tomlinson and Taylor, 1985); intraperitoneal
administration of the enzyme interrupted the transit of E. coli K1
fromgut to brain via the blood circulation in colonised neonatal rat
pups, abrogated meningeal inflammation and prevented death
from systemic infection (Mushtaq et al., 2004; Zelmer et al., 2010;
Birchenough et al., 2017).Other investigationshave also shown that
phage-derived depolymerases have wide utility. For example,
phage-encoded capsule depolymerase sensitised extensively drug-
resistant Acinetobacter baumannii to complement and rescued
normal and immunocompromised mice from lethal peritoneal
sepsis (Liu et al., 2019). Depolymerase increased survival of mice
infected with a lethal bolus of Pasteurella multocida (Chen et al.,
2018) and alginate-selective enzymes can disrupt a number of
bacterial biofilms (Sutherland et al., 2004).
Extended-spectrum b-lactamase-producing clones of
K. pneumoniae have emerged as a global threat to the health of
hospitalised patients and, increasingly, to otherwise healthy
individuals in the community (Paczosa and Mecsas, 2016; Wyres
et al., 2020). The therapeutic challenge has been compounded by the
recent emergence of hypervirulent K. pneumoniae clones associated
with pyogenic liver abscesses, pneumonia, and meningitis in young,
healthy patients (Paczosa and Mecsas, 2016). In consequence, a
number of reports describe the characterisation of K. pneumoniae-
selective capsule depolymerases (recently reviewed by Knecht et al.,
2020) and theydemonstrate efficacy inGalleria (Majkowska-Skrobek
et al., 2016) and murine models of infection (Lin et al., 2014, Lin H.
et al., 2017; Wang et al., 2019). We have characterised 164 recent
clinical isolates ofK. pneumoniae from three hospitals in Thailand by
whole-genome sequencing and phenotypic assays for virulence
markers and defined the frequency of capsular (K) chemotypes
(Loraine et al., 2018) with a view to developing a palette of
depolymerases that would address the most abundant pathogens in
intensive care settings inThailand.A large number of distinctK types
were found in low abundance although four (K2, K51, K1 and K10)
were foundwith a frequency of >5%.Here, we report on the isolation
andmolecular characterisation of phage specific for K1, K2 and K51
K. pneumoniae and describe the properties of their depolymerases
that selectively disrupt capsules associated with these serotypes.
MATERIALS AND METHODS
Reagents
All reagents were supplied by Sigma-Aldrich, Gillingham, UK
unless otherwise specified.
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Bacteria
K. pneumoniae clinical isolates used in this study are detailed in
Table 1. The majority of isolates were fromThammasat University
Hospital (PathumThani Province), Siriraj Hospital (Bangkok) and
Songklanagarind Hospital (Hat Yai, Songkhla Province); these are
major tertiary care hospitals in Thailand. All Thai isolates were
obtained in 2016 (Loraine et al., 2018). K. pneumoniae isolate
NTUH-K2044 has been described by Fang et al. (2004) and
ATCC-43816 by Broberg et al. (2014). Bacteria were cultured in
tryptic soy broth (TSB) and stored at -80°C.
Phage Isolation, Amplification and Host Range
Sewage water samples were collected from the Thai hospitals:
10 ml aliquots of sewage water sample were mixed with 0.3 g TSB
powder, inoculated with 100 ml overnight bacteria culture and
incubated overnight at 37°C in an orbital incubator (200 rpm).
After centrifugation (4,000 rpm; 20 min) supernatants were
filtered (0.45 mm Merck Millipore filter) and maintained at 4°C
prior to use. Individual plaques were obtained using tenfold
dilutions (10-1 to 10-8) of supernatants with the double-layer agar
method (Kropinski et al., 2009): 100 ml overnight culture was
mixed with top agar and poured over a tryptic soy agar (TSA)
plate, 10 ml supernatant was dropped onto the surface and the
plates incubated overnight at 37°C. Plaques were picked with a
sterile tip and transferred to 300 ml sterile SM buffer (Cold Spring
Harbour, 2006) and maintained at 4°C overnight. Serial dilutions
were prepared in SM buffer and used to inoculate TSB containing
200 ml logarithmic phase culture, which was then mixed with top
agar, poured onto TSA plate and the plate incubated overnight at
37°C. Single plaque isolation was repeated three times: plaques
from the third cycle were picked from the plates, transferred to
300 ml sterile SM buffer, maintained at 4°C overnight, serially
diluted in SMbuffer prior to inoculation intoTSB containing 200ml
logarithmic phase bacteria, dilutions mixed with top agar and
mixtures poured onto TSA for overnight incubation at 37°C. For
collection of phage, 10 ml of phage stock was added to 10 ml
logarithmic phase bacteria in TSB and the mixture incubated
overnight at 37°C in an orbital incubator at 200 rpm. The culture
was centrifuged (4,000 rpm; 4°C; 30min) and supernatants filtered
(0.45 mm). Suspensions were stored at 4°C. Phage host range was
determined by spot test; 100 µl logarithmic phase bacterial culture
was mixed with 10 ml 0.75% TSA, the mixture poured onto 10 ml
1.5% TSA plates and 10 µl phage lysate (~109 pfu/ml) spotted onto
the plate prior to overnight incubation at 37°C.All host range assays
were performed in triplicate.
Visualisation of Phage
For transmission electron microscopy (TEM), formvar/carbon
grids (Agar Scientific Ltd., Stansted, UK) were prepared by glow
discharge (10 mA, 10 s) using a Q150R ES sputter coater
(Quorum Technologies Ltd., Lewes, UK). Bacteriophage
suspensions (15 µl) were pipetted onto the surface of the grids
for 30 s before removal with Whatman filter paper. Samples were
then stained by pipetting 15 µl 2% phosphotungstic acid onto the
grids. Excess stain was removed with Whatman filter paper and
grids air dried. Samples were visualised using a JOEL JEM-
2100Plus transmission electron microscope at an accelerating
voltage of 160 Kv.
Genomic DNA Extraction and Sequencing
Phage DNA was extracted using protocol 3.3.3 described by
Pickard (2009). Briefly, 1.8 ml phage lysate was incubated with
TABLE 1 | K. pneumoniae isolates used in this study.
Isolate Location/source Sequence type O type K type
SR7 Siriraj Hospital ST23 O1v2 K1
SR65 Siriraj Hospital ST23 O1v2 K1
TU37 Tammasat University Hospital ST23 O1v2 K1
NTUH-K2044 National Taiwan University Hospital ST23 O1v? K1
SR3 Siriraj Hospital ST14 O1v1 K2
TU18 Tammasat University Hospital ST14 O1v1 K2
TU30 Tammasat University Hospital ST14 O1v1 K2
SG44 Songklanagarind Hospital ST14 O1v1 K2
SG46 Songklanagarind Hospital ST65 O1v2 K2
SR10 Siriraj Hospital ST65 O1v2 K2
SR51 Siriraj Hospital ST86 O1v1 K2
ATCC-43816 American Type Culture Collection ST493 ? K2
SR57 Siriraj Hospital ST16 O3s K51
TU16 Tammasat University Hospital ST16 O3s K51
SG43 Songklanagarind Hospital ST16 O3s K51
SG45 Songklanagarind Hospital ST16 O3s K51
SG79 Songklanagarind Hospital ST16 O3s K51
SR54 Siriraj Hospital ST231 O1v2 K51
TU9 Tammasat University Hospital ST231 O1v2 K51
TU29 Tammasat University Hospital ST45 O3s K10
SR4 Siriraj Hospital ST147 O3l K10
SG95 Songklanagarind Hospital ST629 O3l* K10
TU1 Tammasat University Hospital ST36 O2v2 K102
SG41 Songklanagarind Hospital ST307 O2v2 K102
SG56 Songklanagarind Hospital ST307 O2v2 K102
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10 µg/ml DNase I and 50 µg/ml RNase A for 30 min, then
incubated for a further 30 min with 10 µg/ml Proteinase K and
0.5% SDS, both at 37°C. Mixtures were transferred to phase-lock
Eppendorf tubes, mixed with 500 µl phenol:chloroform:isoamyl
alcohol (25:24:1), centrifuged (1,500 g; 5 min), the aqueous phase
moved to fresh phase-lock tubes and the extraction repeated.
Aqueous phases were then moved to fresh phase-lock tubes and
mixed with 500µl chloroform:isoamyl alcohol (24:1), centrifuged
(6,000 g; 5 min), the aqueous phase removed, mixed with 45 µl
3M sodium acetate (pH 5.2) and 500 µL isopropanol, maintained
at room temperature for 20min, centrifuged (14,000 rpm; 20min),
the pellet washed twice with 70% ethanol, left to dry and suspended
inTEbuffer. DNAqualitywas assessed by restrictiondigestionwith
HindIII-HF(NewEnglandBiolabsUK) followedbyelectrophoresis
on 0.8% agarose gels. In all cases, clear bands indicated absence of
contamination with bacterial DNA; no ethanol contamination was
detected when DNA was subjected to nanodrop analysis. Phage
genomic DNA (~0.5 mg) was sequenced using Illumina HiSeq X10
paired-end sequencing. Annotated assemblies were produced
according to Page et al. (2016). Sequence reads were assembled
de novo with Velvet v1.2 (Zerbino and Birney, 2008) and
VelvetOptimiser v2.2.5 (Gladman and Seemann, 2008).
Assemblies were also made using SPades v1.3.1. (Nurk et al.,
2017) with the -meta option to identify prophage. Reads were
annotated using PROKKAv1.14.6 (Seemann, 2014) using a custom
Caudovirales gene database provided by Dr Andrew Millard,
University of Leicester. The stand-alone scaffolder SSPACE
(Boetzer et al., 2011) was used to refine contig assembly; sequence
gaps were filled using GapFiller (Boetzer and Pirovano, 2012).
Phylogenetic trees were prepared using Archaeopteryx (https://
sites.google.com/site/cmzmasek/home/software/archaeopteryx).
Protein Expression and Purification
Putative depolymerase gene coding sequences were cloned directly
from phage genomes using PCR (conditions in Supplementary
Table 1) by ligation into the pET26b+ expression vector (Merck
KGaA, Darmstadt, Germany) between NdeI-XhoI or HindIII-XhoI
depending on the presence or absence of the pelB leader sequence to
aidprotein solubility.All expressedproteins carriedaC-terminal-his6
tag. Plasmid sequences are shown in Supplementary Data Sheet 1.
Proteins were expressed in T7 express cells (ER2766, NEB) by IPTG
induction atOD600~0.4.Cellswere collectedby centrifugation (5,000
g; 4°C; 15min), the pellet suspended in 40ml binding buffer (50mM
NaH2PO4; 300 mM NaCl; 10 mM imidazole; pH 7.4) and one
protease inhibitor cocktail tablet (Roche Applied Science) together
with 100 µg/ml lysozyme. After maintenance on ice for 30 min, the
lysate was centrifuged (10,000 g; 4°C; 30 min) and the supernatant
loaded onto a 5ml Histrap column housed in an AKTAprime FPLC
system (Cytiva, Amersham, UK). Proteins were eluted with a 30 ml
gradient of loading buffer into elution buffer (binding buffer with 500
mM imidazole), dialysed against storage buffer (binding buffer, no
imidazole; 5ml eluate against 5 l buffer),filtered (0.22 µM) and stored
at -80°C. Protein concentration was determined by Bradford assay.
Enzyme Characterisation
Klebsiella pneumoniae capsules were prepared essentially as
described by Domenico et al. (1989): 200 ml bacterial culture
was mixed with 40 ml 1% Zwittergent 3-14 detergent in 100 mM
citric acid (pH 2.0) for 30 min at 50°C. Bacteria were removed by
centrifugation (16,000 g; 2 min), supernatants mixed with ice
cold ethanol to a final ethanol concentration of 80%, and
maintained at 4°C for 30 min. After centrifugation (16,000 g;
5 min) pellets were air dried, suspended in 40 ml H2O and treated
with DNase and RNase (both 30 µg/ml) for 30 min at 37°C.
Preparationswere lyophilisedafterheat inactivation (65°C;10min).
To determine the impact of depolymerase on capsule viscosity,
enzyme aliquots (final protein concentrations: GBH001_056, 25
ng/µl; GBH038_054, 22.2 ng/µl; GBH019_279, 1.6 ng/µl) were
mixed with 400 mg polymer in 1 ml protein storage buffer and
incubated for 1 h at 37°C; reactions were terminated by
maintenance at 98°C for 5 min and, if required, samples stored
at −20°C before viscometric analysis. Polymer viscosity was
determined using an Anton Paar rolling ball microviscometer
(Anton Paar, Graz, Austria); samples were transferred to a glass
viscometry 1.6 mm diameter capillary containing a solid steel ball.
Viscosity was determined as the time taken for the ball to fall
25 cm through the sample at an angle of 20° to the horizontal; each
automated, timed determination was performed six times.
Degradation of polysaccharide substrate was also determined by
gel electrophoresis. Enzyme aliquots were mixed with 7.5 mg of
substrate in 22.5 ml reaction volume, the reactions terminated as
described above and after electrophoresis using 10% SDS-PAGE,
gels were washed (10% acetic acid; 25% ethanol) after 5, 10 and
15 min at 50°C, stained with 0.1% Alcian blue in 10% acetic acid
and 25% ethanol for 30 min at 50°C and de-stained with wash
buffer at room temperature overnight. Enzyme activity was also
monitored by spotting 10 ml depolymerase onto agar plates seeded
with appropriate K. pneumoniae strains (spot tests). The capacity
of recombinant depolymerases to remove capsule from the surface
of K. pneumoniae was examined by preparation of turbid bacterial
suspensions (OD600 ∼ 1) in 100 ml PBS, enzyme added to give a
final concentration of 1 mg/ml and incubation for 90 min at 37°C.
Negative controls were incubated with PBS. Bacterial suspensions
were combined with nigrosin and examined by phase contrast
microscopy. Area occupied by the capsule was determined using
the microbeJ application of ImageJ (https://imagej.net/Welcome).
RESULTS
Phage Isolation
K. pneumoniae isolates TU37 (capsule K1), TU18 (K2), TU30
(K2), SG44 (K2), SG46 (K2), TU9 (K51), SG43 (K51), SG45
(K51) and SG79 (K51) (Table 1) were used to isolate phage
selective for these capsule types from three filtered sewage water
samples. Sixty-two phage were isolated, encompassing a variety
of distinct host range patterns (Supplementary Table 2); 28 of
these were chosen for further study, based on divergent
morphology, host range, genome size and sequence similarity,
and were ordered into seven groups based on a high degree
(>95%) of nucleotide sequence identity (Table 2). In general,
phage producing plaques on a host carrying the target K-type
lysed other clinical isolates of the same K type, although there
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were exceptions as detailed in Supplementary Table 2 and Table 2.
The majority did not have absolute specificity for K-type: for
example, GBH013 and GBH017, isolated on and with specificity
for isolates carrying the K2 capsule type, were able to lyse all four K1
indicator strains, and the six phage isolated on and active against
K51 strains also lysed two of three K102 indicator strains,
producing incomplete lysis of the third. Incomplete lysis was
independent of virion concentration and is therefore not due to
“lysis from without”. All lytic plaques on fully-susceptible host
strains were surrounded by halos after overnight incubation at 37°C
followed by 3-4 days storage at 4°C, indicating diffusion of soluble
(non-virion) capsule depolymerase into the surrounding bacterial
lawn (Adams and Park, 1956). Representative phage from each of
the seven groups shown in Table 2 were also examined against
K. pneumoniae expressing capsular K-types K5, K20, K15-1, K21,
K24, K25, K28, K54, K103 and K122. GBH029 and GBH054 lysed
the K21 isolate SR95 and GBH001, GBH014, GBH029 and
GBH033 lysed the K28 isolate SR33; in all other cases no lytic
activity was noted.
The genetic relatedness of the 28 phage genomes sequenced in
this study (Figure 1A) in comparison to the 314 from published
studies of Klebsiella phage is shown in Figure 1B. Figure 1A uses
formal designations for the phage (e.g., vB_KpnA_GBH001) but
here and elsewhere in this study the abbreviated form has been
used (e.g., GBH001) for clarity (Adriaenssens and Brister, 2017).
TheKlebsiellaphage genomediversity found inour study paralleled
that in studiesofpreviously sequencedphage (SantiagoandDonlan,
2020; Townsend et al., 2021). A combination of genome sequence
comparison andTEMwas employed to classify the phage in accord
with the most recent International Committee on Taxonomy of
Viruses (ICTV) guidelines (Adriaenssens et al., 2020); five
(GBH054, GBH055, GBH056, GBH060, GBH061) were assigned
to the family Siphoviridae (order Caudovirales), five (GBH019,
GBH020, GBH023, GBH033, GBH035) to the Myoviridae (order
Caudovirales), fifteen (GBH001, GBH002, GBH003, GBH005,
GBH007, GBH013, GBH014, GBH017, GBH018, GBH038,
GBH039, GBH045, GBH046, GBH049, GBH050) to the
Autographiviridae (order Tubulavirales) and three (GBH026,
GBH027, GBH029), to the Drexlerviridae (order Tubulavirales).
There was complete concordance between assignments based on
genome sequence and morphology as determined by TEM;
representative images from each phage family together with
corresponding plaque morphology are shown in Figure 2.
From the genome sequence data the 28 phage showed a wide
range of genome sizes (Table 2). Four phage selective for either
capsular K1 or K2 strains possessed genomes of <50 kb, seven
genomes of 50-100 kb and seven genomes of 100-200 kb. Three
K51-selective phage displayed non-identical genomes of 348 kb
and consequently fell into the category of jumbo (Yuan and Gao,
2017) also known as huge (Al-Shayeb et al., 2020) phage
characterised by genomes of >200 kb. As isolation-based
methods select against large phage (Yuan and Gao, 2017), only
94 jumbo phage have been described following isolation and only
three of these, with a high degree of sequence similarity, are
Klebsiella spp virions (Šimoliūnas et al., 2013; Pan et al., 2017;
Mora et al., 2021): these have genomes of 345.8 kb, making phage
GBH019, GBH020 and GBH023 (Table 2) amongst the largest
Klebsiella phage described and sequenced to date.
Phage Genome Analysis
The 28 phage selected for sequencing were found to belong to
seven groups with members sharing MASH (Ondov et al., 2016)
DNA sequence similarity of >95%. These groups are exemplified
by phage GBH001 (45 kb), GBH014 (41 kb), GBH019 (348 kb),
GBH029 (50 kb), GBH033 (166 kb), GBH038 (44 kb) and
GBH054 (59 kb). Phage GBH038 and GBH50 share 96.5%
MASH sequence identity but have divergent gene orders. As
others have noted (Townsend et al., 2021), analysis of genome
assemblies using metaSPAdes showed the presence of prophage
in sequenced lysate preparations of lytic phage GBH001
(prophage genome size 48.6 kb) and GBH029 (43.4 kb) and
closely related phage. However, these were low coverage
assemblies compared to those of the lytic phage with coverage
depths of <7% compared to the main phage assembly.
Presumably these prophage were released from the host
genome during phage lysate preparation. Prophage from K.
pneumoniae on which GBH001 formed plaques were 48.6 kb
in length and contained genes associated with integration and
excision from host genomes such as integrases and transposases,
and a cro repressor protein. GBH029 and similar phage contain a
prophage of 43.4 kb whose genomes contain integrase,
transposase and putative excisionase genes.
Jumbo Phage GBH019
The genome of phage GBH019, at 347,546 bp, is the largest of
any K. pneumoniae phage sequenced to date. It contains 534
CDSs and six tRNA genes with a coding gene density of 90.2%
and GC% of 32.0. Annotations were attributed to 141 CDSs
(shown in colour in Figure 3) leaving a total of 393 (73.6%) CDSs
of unknown function. GBH019 shows high similarity to
previously described jumbo phage Muenster (Mora et al.,
2021), K64-1 (Pan et al., 2017) and vB_KleM-RaK2
(Šimoliūnas et al., 2013) with DNA similarity values calculated
using MASH of 98.2–98.4% but with highly dissimilar gene
organisation (Supplementary Figure 1). Examination of the
pangenome of these four phage using Roary 3.13 (Page et al.,
2015) showed that 384 genes were common to all genomes
(BLASTP > 90%). The genome of GBH019 has three putative tail
fibre protein genes (Figure 3) as well as tail spike and other tail-
associated protein genes. These genes encode structures involved
in host receptor recognition and binding, and the presence of
several such structures in the genomes of these large phage is
associated with extended host ranges (Pan et al., 2017). One of
these putative tail fibre genes, corresponding to GBH019 gene
00383 is common to all four phage and is highly conserved
(>98% DNA sequence identity, determined by Clustal F).
GBH019 contains six tRNA genes in common with those of
phage Muenster, with K64-1 having seven and KleM-RaK2 eight.
GBH019 also has many genes involved in nucleotide metabolism,
DNA transcription, replication and repair including a DNA
polymerase and DNA and RNA ligases and at least two
endonucleases (Figure 3). These genes are presumably
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TABLE 2 | K. pneumoniae phage isolates sequenced in this study, showing patterns of lytic activity against various K. pneumoniae K-types.
Phage Hosta kbb SR7 SR65 TU37 NTUH-K2044 SR3 TU18 SG44 SR10 SR51 ATCC-43816 SR57 TU16 SG45 SR45 TU9 TU29 SR4 SG95 TU1 SG41 SG56
K1 K2 K51 K10 K102
GBH001 TU37 45.96 ++c + ++ ++ - - - + - - - + - - - - - - - - -
GBH002 TU37 45.97 ++ + ++ ++ - - - - - - - + - - - - - - - - -
GBH003 TU37 45.96 ++ + ++ + - - - - - - - + - - + - - - - - -
GBH005 TU37 45.96 ++ + ++ ++ - - - - - - - + - - - - - - - - -
GBH007 TU37 45.96 ++ + ++ ++ - - + ++ - - - + - - - - - - - - -
GBH014 SG44 41.70 + - - - ++ ++ ++ ++ ++ ++ - - - - - - - - - - -
GBH013 SG44 41.70 ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ - + - - - - - - - - -
GBH017 SG44 41.09 ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ - + - - - - - - - - -
GBH018 SG44 40.87 - - - - ++ ++ ++ ++ - ++ - ++ - - - - - - - + -
GBH019 TU9 347.55 - - - - - - + - - - ++ ++ ++ ++ ++ - - - + ++ ++
GBH020 TU9 347.54 - - - - - - - - - - ++ ++ ++ ++ ++ - - - + ++ ++
GBH023 TU9 347.55 - - - - - - - - - - ++ ++ ++ ++ ++ - - - + ++ ++
GBH029 SG43 49.92 - - - - - - ++ + - + - ++ - - - - + - - - -
GBH026 SG43 50.49 - - - - - ++ ++ + - ++ - ++ - + + - + - - + -
GBH027 SG43 50.49 - - - - - ++ ++ + - + - ++ - + + - + - - + -
GBH033 SG45 165.75 - - - - - - + - - + - ++ + + - - - - - - -
GBH035 SG45 165.75 - - - - - - ++ + - + - ++ + + - - - - - - -
GBH038 SG46 43.73 - - - - ++ ++ ++ ++ ++ ++ - - - - - - - - - - -
GBH039 SG46 43.73 - - - - ++ ++ ++ ++ ++ ++ - - - - - - - - - - -
GBH045 TU18 44.03 - - - - ++ ++ ++ ++ ++ ++ - - - - - - - - - - -
GBH046 TU18 44.65 - - - - ++ ++ ++ ++ ++ ++ - - - - - - - - - - -
GBH049 TU30 44.22 - - - - ++ ++ ++ ++ ++ ++ - - - - - - - - - - -
GBH050 TU30 44.20 - - - - ++ ++ ++ ++ ++ ++ - - - - - - - - - - -
GBH054 SG79 58.59 - - - - - ++ ++ ++ + - - ++ ++ - ++ - - - - - -
GBH055 SG79 58.52 - - - - - ++ ++ ++ - - + ++ ++ + ++ - - - - - -
GBH056 SG79 58.52 - - - - - ++ ++ ++ - - + ++ + - ++ - - - - - -
GBH060 SG79 58.52 - - - - - - ++ ++ - - + ++ ++ - ++ - + - - - -
GBH061 SG79 58.52 - - - - - - + ++ - - ++ ++ ++ + ++ - - - - - -
aclinical isolates detailed in Table 1.
bgenome length determined from whole-genome data.
cclear plaque, ++; +, incomplete lysis; -, no lysis. Determined by spot assay, phage concentration ~1010 virions/ml.









































FIGURE 1 | Phylogeny of Thai K pneumoniae- selective phage. (A) MASH tree with degree of genetic similarity amongst the 28 phage genomes sequenced in this
study. (B) Phylogenetic tree prepared using Archaeopteryx showing the relationship of the 28 phage genomes (in red) to 314 published Klebsiella phage genomes.
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FIGURE 2 | Representative transmission electron micrographs and plaque morphology of the seven exemplars for each of the genetically distinct phage
groups defined in this study and shown in Table 2. (A) GBH001 (mean capsid diameter 63.4 nm; mean tail length N/A; n = 10) (B) GBH014 (64.0 nm; N/A;
n = 7) (C) GBH019 (132.7 nm; 163.4 nm; n = 9) (D) GBH029 (73.8 nm; 188.8 nm; n = 7) (E) GBH033 (86.7 nm; 105.2 nm; n = 8) (F) GBH038 (72.0 nm;
N/A; n = 6) (G) GBH054 (81.2 nm; 256.4 nm; n = 11).
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involved in sophisticated re-purposing of the host DNA and
protein synthesis machinery to phage particle biosynthesis.
GBH019, in common with the three other similar phage has a
putative CRISPR array of the sequence CCCAGTATTCATGC
GGGTTGTAGGAATTAGGGACAC although no Cas genes are
present in these genomes.
Phage GBH033
With the second largest phage genome in this study (165,752bp),
GBH033 is similar to several Myoviridae genomes (>95%
BLASTN nucleotide similarity) including Klebsiella virus JD18
(Genbank accession number KT239446). It has an AT-rich
genome with %GC of 39.5 and contains 290 CDSs which we
annotated with functions or putative functions. The genome of
GBH033 contains 16 tRNA genes, the same number as found in
the genome of phage JD18.
Phage GBH001 and GBH038
Phage GBH001 and GBH038 have genome sizes of 44,964 and
43,726 bp respectively. They share 93.4% DNA similarity,
determined using MASH, and have 56 and 54 CDSs
respectively. We ascribed functions or putative functions to 31
of 56 GBH001 and 29 of 54 GBH038 genes. Their genomes are
more GC-rich than that of GBH019 with GC% of 54.2 and 54.3,
compared to 32.2. The most closely related genomes of both
phage determined by BLASTN homology are phage of the family
Autographiviridae (subfamily Slopekvirinae, genus Drulisvirus)
whose genomes share <92% BLASTN DNA similarity and
therefore both phage may represent a new species within this
subfamily as <95% BLASTN similarity equates to new species
(Adriaenssens et al., 2020).
Phage GBH014
The genome length of phage GBH014 is 40,697 bp, with GC% of
53.2, and the phage shares 96.2% BLASTN similarity (over 85%
of its genome) with the Klebsiella Autographidae phage 066028
(Genbank accession MW042796.1) that is currently designated
as an unclassified Przondovirus. However, GBH014 may represent
a new species of Klebsiella phage as it shares <5% DNA similarity
over its whole genome with any phage genome described thus far.
FIGURE 3 | Circular genomic map of Jumbo phage GBH019. Genes involved in virion structure (orange), host interaction (green), nucleotide metabolism (pink), DNA
replication and repair (blue), and DNA transcription (magenta) are shown as the positions of six tRNAs (red) and a putative CRISPR array (purple). %GC is shown in
the centre of the figure. Hypothetical proteins are shown in cream. Figure generated using DNA Plotter release 18.1.0.
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We were able to annotate functions or putative functions to 25 of
the 51 predicted CDSs in the GBH014 genome.
Phage GBH029
GBH029 has a genome of 49,924 bp, a GC% of 51.2% and is most
similar to Klebsiella phage Sweeney (Genbank accession
NC_049839.1) which is an unclassified Webervirus in the
family Drexlerviridae. Functions or putative functions were
annotated to 35 of the 77 CDSs in this genome.
Phage GBH054
The genome of phage GBH054 is 58,588 bp long and has a GC%
of 56.2. Functions or putative functions could only be annotated
to 28 of 79 CDSs in this genome. This genome is most similar to
that of the Siphoviridae phage Soft (Genbank accession
MN106244.1). BLASTN comparison of both genomes revealed
93.84% sequence identity over 84% of the GBH054 genome,
indicating that this phage may be a new species of Siphovirus.
Identification and Expression of Phage
Depolymerase Genes
To identify genes encoding depolymerases with the capacity to
degrade capsular polysaccharides produced by K. pneumoniae K1,
K2 and K51 isolates, BLASTX (States and Gish, 1994) was used to
search a customised library (Supplementary Table 3) of 25
published phage-encoded K. pneumoniae capsule depolymerases.
Phage GBH001 displayed lytic activity against the four clinical
isolates of K1 capsule type (Table 2). The search identified two
potential GBH001-encoded depolymerase genes, GBH001_048
(541 residues) and GBH001_056 (651 residues). The former was
matched to multiple tail fibre and tail spike proteins, and to other
putative depolymerase proteins using JACKHMMER (Finn et al.,
2015); we also identified an N-terminal match with a tail fibre
protein using the EMBL protein family database InterProScan
(Quevillon et al., 2005). It was cloned and expressed as described
inMaterials and Methods but displayed no capsule depolymerase
activity against K1 capsule. The latter showed >96% identity with
known K1-selective depolymerases, was matched to tail fibre
proteins using JACKHMMER (Finn et al., 2015) with the
reference proteomes database and contained a pectin-lyase fold
(residues 265-568) as determined with the EMBL protein family
database InterProScan. GBH001_056 was inserted between
pET26b+ NdeI and XhoI sites and grown for 16 h at 26°C
following induction with 0.01 mM IPTG at OD600 ~0.4. Spot tests
indicated that the his6-tagged, affinity-purified protein possessed
depolymerase activity against the K1 capsule but not against K2,
K51, K10 and K102 capsules (Table 3). Depolymerase
GBH001_056 possessed no activity against Thai clinical isolates
expressing the K20, K24, K15-1, K21, K25, K103, K122, K28, K5,
K54, K62 and K74 capsules; these K-types were found with
relatively high frequency (incidence >1.5%) in clinical isolates
from our Thai K. pneumoniae collection (Loraine et al., 2018).
Phage GBH014 and GBH038 were both able to lyse the six K.
pneumoniae K2 isolates examined (Table 2). BLASTX revealed
three potential K2 depolymerase candidate genes, GBH014_001
(215 residues) and GBH014_051 (433 residues) from phage
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GBH038. With GBH014_001, JACKHMMER showed matches
to phage tailspikes and tail fibres, and to tailspike 63D sialidase
from phage 1611E-K2-1, shown to be an active K2 depolymerase
(Wang et al., 2020). In addition, a galactose binding domain
(residues 65-214) was identified by InterProScan; galactose is a
constituent of the K2 capsular polysaccharide (Clements et al.,
2008). GBH014_051 showed matches to tail fibres using
JACKHMMER and to serralysin metalloprotease using
InterProScan. We were unable to purify and test this protein.
GBH014_001 was cloned into pET26b+ both with and without a
pelB tag on the N-terminus to migrate the protein to the periplasm
and aid folding. GBH014_001 expressed better without the
addition of the pelB tag, but could not be purified without
denaturation of the protein. Refolded protein possessed no
depolymerase activity when tested against K1, K2 and K51
capsules. GBH038_054 (577 residues) showed >98% amino acid
homology with vP_KpnP_KpV74_564, the sole K2 depolymerase
published to date (Solovieva et al., 2018) and was inserted between
the HindIII and XhoI sites of pET26b+ with and without N-
terminal pelB and grown for 16 h at 16°C following induction with
0.01 mM IPTG at OD600 ~0.4. The gene was expressed only in the
presence of pelB. In spot tests, affinity-purified protein degraded
the K2 capsule, but not K1, K51, K10 or K102 capsules (Table 3),
or any of the capsules described in the preceding paragraph.
Only jumbo phage GBH019 and closely related phage were
able to lyse the five K. pneumoniae K51 isolates examined
(Table 2). Putative depolymerase genes were restricted to a
30,000 bp section of the GBH019 genome (125,000-155,000 bp)
where eight CDSs (278-285) were located in series; such clustering
of depolymerase genes is consistent with a recent study of jumbo
K. pneumoniae phage phiK64-1 (Pan et al., 2017). There are
currently no published K51 depolymerase sequences and none
of the eight putative depolymerases showed sufficient homology
with currently available sequences to guide the identification of a
K51 depolymerase gene. Attempts were therefore made to clone
and express these eight genes. Although all showed some degree of
alignment with sequences in the protein database (Supplementary
Table 3), the majority could not be expressed as enzymatically
active protein. GBH019_279 (809 residues) showed limited
alignment with tail fibre and tail spike proteins within the first
200 residues. This was supported by InterProScan analysis which
predicted a pectin-lyase fold between residues 139 and 532, and
Phyre2 modelling (Kelley et al., 2015) which predicted a hydrolase
with 98.7% confidence, suggesting potential depolymerase activity
but with no link to the specific K51 capsule target. BH019_279 was
cloned into pET26b+ with pelB, the gene inserted between HindIII
and XhoI sites, grown for 16 h at 16°C following induction with
0.01 mM IPTG at OD600 ~0.4 and the protein affinity-purified in
soluble form. Spot tests indicated that this gene product degraded
the K51 capsule but had no effect on any other capsule types in our
K-type panel described above.
GBH001_056 (K1 depolymerase), GBH038_054 (K2
depolymerase) and GBH019_279 (K51 depolymerase) were
assigned molecular weights of 71 kDa, 66 kDa and 93 kDa
respectively using SDS-PAGE and were in line with values
predicted from the size of the coding region of each gene.
Characterisation of K1, K2
and K51 Depolymerases
The capacity of each depolymerase to degrade their respective
primary substrates was determined by observing reductions in
polysaccharide molecular mass and polysaccharide viscosity.
Capsular substrates were purified from two K1 (SR7 & SR65),
two K2 (SR3 & SR10) and two K51 (TU16 & SR54) clinical
isolates. Essentially identical results were obtained for each K-type-
specific pair so only data for the SR65, SR3 and TU16 polymers is
presented in Figure 4. The three enzymes rapidly reduced the
molecular mass with evidence of degradation after less than 1 min
incubation time. After 60 min incubation each polymer appeared
substantially degraded although depolymerisation of K2 and K51
polymers appeared greater than for K1. Reduction in molecular
mass was accompanied in all cases by a large decrease in polymer
viscosity using an Anton-Paar rolling ball viscometer. K.
pneumoniae SR65 (K1), SR3 (K2) and TU16 (K51) were also
employed to examine the capacity of the three depolymerases to
remove the primary target capsule. The area occupied by the
capsule was determined before addition of enzyme (final
concentration 25 ng/µl for K1 depolymerase, 25 ng/µl for K2
depolymerase and 1.6 ng/µl for K51 depolymerase) and after
90 min incubation at 37°C following addition of the respective
depolymerase. As noted in an earlier study (Loraine et al., 2018),
there were significant differences in capsule size between each of
the clinical isolates. K1, K2 and K51 depolymerases removed
completely the capsules surrounding, respectively, isolates SR65,
SR3 and TU16 (Figure 5). No significant differences were seen
between bacteria prior to incubation and following 90 min
incubation with PBS. Phase contrast images for K. pneumoniae
SR65 are also shown in Figure 5.
DISCUSSION
The ideal candidate for capsule depolymerase therapy would be a
difficult-to-treat infection caused by a single bacterial infectious
agent producing a protective capsule that does not vary in its
chemical composition between isolates and is essential for
pathogenesis. Inhalation anthrax, due to B. anthracis strains that
universally produce a poly-g-D-glutamic acid capsule that is
absolutely required for systemic, often lethal infection (Mock and
Fouet, 2001), is probably the only infectious condition in which
these tenets hold, so capsule depolymerisation as a principle for the
therapy of other bacterial infections will be conditioned by a degree
of structural variability, sometimes very large, at the cell surface. Our
study confirms previous work showing that the host range of K.
pneumoniae phage is to a large extent governed by carriage of
distinct capsule depolymerases, each with a narrow substrate
specificity (reviewed by Knecht et al., 2020). In a particularly
illustrative example of this principal, the capacity of phage FK64-
1 to infect K. pneumoniae belonging to eight capsule chemotypes
was facilitated by carriage by the phage of eight capsule
depolymerases, each capable of degrading only one structurally
distinct capsule (Pan et al., 2017). Strains of K. pneumoniae
elaborate a wide array of different capsule types (Wyres et al.,
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2020) and this population diversity was reflected in the large
number of distinct K-types we found in our analysis of Thai
nosocomial isolates (Loraine et al., 2018); only one K-type (K2)
was found in more than 10% of total isolates and only six were
found with an incidence of 4.5% or more. Successful application of
depolymerase therapy will therefore require a cocktail of enzymes in
much the same way as proposed from phage therapy of Klebsiella
infections (Townsend et al., 2021), unless personalised therapy can
be augmented in tandem with rapid and accurate strain
identification and K-typing.
Although bacteria have been exploited as occasional sources
of capsule depolymerase (Avery and Dubos, 1930; Scorpio et al.,
2007; Stabler et al., 2013), phage remain the primary source of O-
glycosyl hydrolases and lyases with the capacity to selectively
degrade a wide range of capsules (Knecht et al., 2020), including
those from K. pneumoniae, and for the dispersal of biofilms
(Rumbaugh and Sauer, 2020). The capsular diversity of K.
pneumoniae correlates to a correspondingly high degree of
variation of phage genotypes that have evolved a lifestyle
enabling lytic cycles within specific K-type hosts, with the
consequence that we were able to isolate a diverse selection of
phage, belonging to four families and displaying a wide range of
genome sizes (41-348 kb), from hospital sewage using three
different K-types as host. The majority of these phage were
distinct from, but genomically related to, phage described in
previous studies (Figure 1B). Plaques from all phage developed
halos when plated on their primary and on the majority of
secondary hosts, indicating the presence of a soluble form of
capsule depolymerase that diffuses into the surrounding agar
from the plaque during incubation. Genomic analyses were
complicated by the presence of prophage sequences in a small
number of DNA preparations that were presumably released
from the host genome during phage lysate preparation as a
consequence of host DNA damage, or prophage may have been
induced by the lytic phage (Raya and Hebert, 2009; Townsend
et al., 2021). It is however unlikely that this low level of
contamination would have compromised the host range
determined in this study (Table 2 and Supplementary Table 2).
Phage-encoded capsule depolymerases are predominantly
located in receptor binding proteins (RBPs) structured as tail
fibres or tailspikes. In situ, these structures form trimers and each
unit generally consists of a conserved N-terminal anchor domain
that aids phage self-assembly, a K-type-variable central b-helical
domain for host recognition and catalysis, and a C-terminal
domain responsible for trimerisation and receptor recognition
(Latka et al., 2017; Latka et al., 2019). Although direct evidence is
lacking, it is generally accepted that both the soluble and
integrated forms of RBP can freely diffuse through an agar
matrix and that soluble and integrated monomers are
structurally identical (Latka et al., 2017). However, due to their
aggregative properties and multi-domain structure, RBPs are
likely to form aqueous microparticulate dispersions rather than
true solutions (Chi et al., 2003) and this may compromise high
yield RBP expression. In the current study, as well as in our
previous work (Leggate et al., 2002; Negus and Taylor, 2014),
issues of solubility and low yield were encountered which in the
A B C
FIGURE 4 | Degradation of high-molecular-weight capsular polysaccharide from K. pneumoniae SR65 (A), SR3 (B) and TU16 (C) following incubation at 37°C with
the corresponding K1, K2 and K51 depolymerases. 10% SDS-PAGE gels; 5 ml Color Prestained Protein Standard, Broad Range (10-250 kDa) (New England Biolabs
UK) as ladder; 22.5 ml loaded into each lane. Enzyme-mediated reductions in polymer viscosity as determined by Anton-Paar rolling ball viscometry are also shown
alongside the corresponding gels. No polymer degradation was observed in the absence of enzyme. ****P = < 0.0001 (unpaired t-test with Welch’s correction
between treated and untreated groups).
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current study were in part overcome by introduction of the pelB
leader sequence into the plasmid vector, which directs the
protein to the bacterial periplasm. Even so, a number of
putative depolymerase genes identified in our screen could not
be expressed as active protein in spite of repeated efforts: one
possible way towards simplification of expression of a range of
highly catalytic depolymerases could involve excision of the
central catalytic domain of the RBP, where expression is more
likely to lead to a fully soluble, enzymatically active polypeptide
(Squeglia et al., 2020).
All seven exemplary phage that we studied in detail were
closely related to other, previously described Klebsiella virions
(Figure 1B), even though they were isolated from widely
dispersed geographical regions. Of interest was the isolation of
the jumbo phage GBH019, the source of the K51 depolymerase
described herein, that counts amongst the largest Klebsiella
phage isolated to date. In common with other jumbo phage,
the GBH019 genome contained multiple putative depolymerase
genes and this phage may be a source of enzymes for the
degradation of the less abundant K-types that we encountered
in our study of nosocomial Thai isolates (Loraine et al., 2018).
Although relatively few jumbo phage have been isolated and
characterised to date, direct sequencing of phage DNA from
diverse ecosystems has revealed that they are highly abundant
(Al-Shayeb et al., 2020) and as they are excluded from typical
phage preparations processed using membrane filters (Yuan and
Gao, 2017) they are unlikely to be recovered unless special
precautions are employed during their isolation. In common
with other jumbo phage, the GBH019 genome carries a large
number of genes for de novo synthesis of purines and
pyrimidines, DNA and RNA polymerases and interconversion
of nucleotide phosphorylation states (Figure 3). As has been
FIGURE 5 | Box and whiskers plot of the impact on capsules of the target K. pneumoniae isolates SR65 (K1), SR3 (K2) and TU16 (K51) following 90 min incubation
at 37°C with the corresponding K1, K2 and K51 depolymerases. SR65 Neg, negative control (PBS incubation), n = 319, mean capsule area mm2 3.41 ± 1.00 (Mean ±
1SD); SR65 Pos, K1 depolymerase-exposed, n = 74, 1.49 ± 0.34; SR3 Neg, n = 119, 1.96 ± 0.58; SR3 Pos, n = 66, 1.41 ± 0.42; TU16 Neg, n = 84, 1.54 ± 0.42;
TU16 Pos, n = 170, 1.36 ± 0.31. ****P = < 0.0001, ***P = < 0.002 (unpaired t-test with Welch’s correction between treated and untreated groups). Also shown: phase
contrast microscopy images of nigrosin staining for isolate SR65 (K1) after 90 min incubation in PBS (A) and with K1 depolymerase (B). Capsule can be seen in (A) as a
bright halo around the cell.
Blundell-Hunter et al. Phage-Encoded Klebsiella pneumoniae Depolymerases
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org June 2021 | Volume 11 | Article 68609013
previously noted (Al-Shayeb et al., 2020) these gene sets are similar
to those of small bacteria and archaea with restricted symbiotic
lifestyles (Castelle et al., 2018), may reduce the dependence of
jumbo phage on their bacterial hosts and broaden their host range
by acquisition of new genetic information, as reflected by the
presence of multiple depolymerase genes. The presence of
CRISPR-Cas systems is also a feature of jumbo phage and may
be involved in the redirection of bacterial host biosynthesis toward
phage-encoded functions as well as contribute to host-directed
elimination of incoming phage. Indeed, the first description of
phage-encoded CRISPR-Cas showed the system was able to
counteract a phage inhibitory chromosomal island of the
bacterial host (Seed et al., 2013).
The increasing number of Klebsiella phage genomes in the
public domain show certain trends in their genome sequences.
Whereas most of the phage genomes in this study and in public
databases have genomes with %GC of 50-55, similar to that of
their bacterial host (56-57), jumbo phage genomes had markedly
more AT–rich genomes with ~32% GC. A group of phage
genomes, including that of phage GBH033 from this study, are
also relatively AT-rich with GC% of ~40%. These two groups of
phages are notable for their content of multiple tRNA genes that
may serve to lessen the possible impact of divergent codon usages
in their genomes when subverting their hosts’ metabolism.
Comparative genomic analyses of our phage genomes with
those in the databases revealed a number of phages that may
represent novel phage species (with >5% sequence divergence
and other differences) according to recent guidance from the
ICTV (Adriaenssens et al., 2020). The increasing number of
Klebsiella phage genomes deposited in databases increases our
basic knowledge of gene composition and key phage phenotypic
characteristics such as host range if appropriate metadata is
available. However, difficulties in assigning functions to the
majority of Klebsiella phage genes is an issue that is especially
marked in jumbo phage genomes, where approximately three
quarters of genes have no annotated function.
The trend toward untreatable, invasive K. pneumoniae
infections shows no signs of abating and is being driven by the
emergence and rapid spread of multi-drug-resistant forms. The
problem is particularly acute in Asia, where hypervirulent K.
pneumoniae clones associated with pyogenic liver abscesses,
pneumonia, and meningitis in younger, otherwise healthy
patients were first recognised, and as a consequence we have
focused our efforts on finding alternative approaches to Klebsiella
infections using recent clinical isolates from intensive care patients
in Thailand (Loraine et al., 2018). There are clear advantages as
well as obvious disadvantages in targeting capsule removal as an
alternative therapeutic paradigm. Although there is substantial
data from animal models showing that administration of capsule
depolymerase under tightly controlled conditions during the early
phase of infection with a known pathogen can rapidly resolve
infection and prevent symptoms and death, there is no evidence
that the approach would reduce morbidity and mortality in
immunocompromised patients with established infections who
are sick enough to be cared for in intensive care units. The
complex array of surface-structure-related phenotypes of
K. pneumoniae encountered in nosocomial infections will also
complicate therapy. However, the capsule is the major
determinant of virulence in Klebsiella, conferring a high degree
of resistance to complement (Merino et al., 1992; Short et al., 2020)
and to phagocytosis (Williams et al., 1983) and is rapidly and
efficiently destroyed, in vitro and in situ, by each enzyme that
we evaluated.
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Supplementary Figure 1 | Genomic comparison of four K. pneumoniae jumbo
phage: Muenster (top), GBH019, K64-1, and vB_KleM-RaK2 (bottom) highlighting
regions of gene similarity and synteny. Red bars indicate >99% BLASTN similarity
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between pairs of phage strains. Generated using Artemis Comparison Tool (Carver
et al., 2005) with pairwise BLASTN comparisons using default parameters for highly
similar sequences.
Supplementary Table 1 | Primers andconditions for cloningof depolymerasegenes.
Supplementary Table 2 | Host range of 62 K. pneumoniae phage isolated from
Thai sewage.
Supplementary Table 3 | Published protein sequences of phage-encoded K.
pneumoniae depolymerases employed for BLASTX search of Thai K. pneumoniae
phage genomes.
Supplementary Table 4 | Accession numbers for sequenced phage. Formal
numbering of phage is affirmed in this table.
Supplementary Data Sheet 1 | Sequences of plasmids used in this study.
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